{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:07:50Z","timestamp":1792825670455,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005855","name":"Universidade Nova de Lisboa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005855","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease that affects nerve cells in the brain and spinal cord, causing loss of muscle control, muscle atrophy and in later stages, death. Diagnosis has an average delay of 1 year after symptoms onset, which impairs early management. The identification of a specific disease biomarker could help decrease the diagnostic delay. MicroRNA (miRNA) expression levels have been proposed as ALS biomarkers, and altered function has been reported in ALS pathogenesis. The aim of this study was to assess the differential expression of plasma miRNAs in ALS patients and two control populations (healthy controls and ALS-mimic disorders). For that, 16 samples from each group were pooled, and then 1008 miRNAs were assessed through reverse transcription-quantitative polymerase chain reaction (RT-qPCR). From these, ten candidate miRNAs were selected and validated in 35 ALS patients, 16 ALS-mimic disorders controls and 15 healthy controls. We also assessed the same miRNAs in two different time points of disease progression. Although we were unable to determine a miRNA signature to use as disease or condition marker, we found that miR-7-2-3p, miR-26a-1-3p, miR-224-5p and miR-206 are good study candidates to understand the pathophysiology of ALS.<\/jats:p>","DOI":"10.1007\/s12035-023-03520-7","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T09:02:26Z","timestamp":1690966946000},"page":"7104-7117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Differential Expression of miRNAs in Amyotrophic Lateral Sclerosis Patients"],"prefix":"10.1007","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5632-1095","authenticated-orcid":false,"given":"Bruno Costa","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno","family":"Peixinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Pisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Gromicho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Catarina","family":"Pronto-Laborinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Rueff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamede","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio Sebasti\u00e3o","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,2]]},"reference":[{"key":"3520_CR1","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A et al (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:17071. https:\/\/doi.org\/10.1038\/nrdp.2017.71","journal-title":"Nat Rev Dis Primers"},{"key":"3520_CR2","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","volume":"390","author":"MA van Es","year":"2017","unstructured":"van Es MA, Hardiman O, Chio A et al (2017) Amyotrophic lateral sclerosis. Lancet 390:2084\u20132098. https:\/\/doi.org\/10.1016\/S0140-6736(17)31287-4","journal-title":"Lancet"},{"key":"3520_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrneurol.2015.57","volume":"11","author":"X Paez-Colasante","year":"2015","unstructured":"Paez-Colasante X, Figueroa-Romero C, Sakowski SA et al (2015) Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era. Nat Rev Neurol 11:266\u2013279. https:\/\/doi.org\/10.1038\/nrneurol.2015.57","journal-title":"Nat Rev Neurol"},{"key":"3520_CR4","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s00415-019-09652-y","volume":"267","author":"L Xu","year":"2020","unstructured":"Xu L, Liu T, Liu L et al (2020) Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol 267:944\u2013953. https:\/\/doi.org\/10.1007\/s00415-019-09652-y","journal-title":"J Neurol"},{"key":"3520_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.tig.2018.03.001","volume":"34","author":"HP Nguyen","year":"2018","unstructured":"Nguyen HP, Van Broeckhoven C, van der Zee J (2018) ALS genes in the genomic era and their implications for FTD. Trends Genet 34:404\u2013423. https:\/\/doi.org\/10.1016\/j.tig.2018.03.001","journal-title":"Trends Genet"},{"key":"3520_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.32604\/biocell.2021.014343","volume":"45","author":"H Wang","year":"2021","unstructured":"Wang H (2021) Phylogenetic analysis of microRNA biomarkers for amyotrophic lateral sclerosis. Biocell 45:547\u2013561. https:\/\/doi.org\/10.32604\/biocell.2021.014343","journal-title":"BIOCELL"},{"key":"3520_CR7","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1007\/s12035-017-0537-z","volume":"55","author":"P Rinchetti","year":"2018","unstructured":"Rinchetti P, Rizzuti M, Faravelli I, Corti S (2018) MicroRNA metabolism and dysregulation in amyotrophic lateral sclerosis. Mol Neurobiol 55:2617\u20132630. https:\/\/doi.org\/10.1007\/s12035-017-0537-z","journal-title":"Mol Neurobiol"},{"key":"3520_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.mad.2018.03.005","volume":"174","author":"A Dolinar","year":"2018","unstructured":"Dolinar A, Ravnik-Glava\u010d M, Glava\u010d D (2018) Epigenetic mechanisms in amyotrophic lateral sclerosis: a short review. Mech Ageing Dev 174:103\u2013110. https:\/\/doi.org\/10.1016\/j.mad.2018.03.005","journal-title":"Mech Ageing Dev"},{"key":"3520_CR9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/fneur.2019.00291","volume":"10","author":"NS Verber","year":"2019","unstructured":"Verber NS, Shepheard SR, Sassani M et al (2019) Biomarkers in motor neuron disease: a state of the art review. Front Neurol 10:291. https:\/\/doi.org\/10.3389\/fneur.2019.00291","journal-title":"Front Neurol"},{"key":"3520_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","volume":"1","author":"R Mayeux","year":"2004","unstructured":"Mayeux R (2004) Biomarkers: potential uses and limitations. Neurotherapeutics 1:182\u2013188. https:\/\/doi.org\/10.1602\/neurorx.1.2.182","journal-title":"Neurotherapeutics"},{"key":"3520_CR11","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3892\/or.2016.4913","volume":"36","author":"BC Gomes","year":"2016","unstructured":"Gomes BC, Martins M, Lopes P et al (2016) Prognostic value of microRNA-203a expression in breast cancer. Oncol Rep 36:1748\u20131756. https:\/\/doi.org\/10.3892\/or.2016.4913","journal-title":"Oncol Rep"},{"key":"3520_CR12","doi-asserted-by":"publisher","unstructured":"Gomes BC, Honrado M, Armada A et al (2020) ABC efflux transporters and the circuitry of miRNAs: kinetics of expression in cancer drug resistance. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21082985","DOI":"10.3390\/ijms21082985"},{"key":"3520_CR13","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3390\/ijms21051714","volume":"21","author":"M Ravnik-Glava\u010d","year":"2020","unstructured":"Ravnik-Glava\u010d M, Glava\u010d D (2020) Circulating RNAs as potential biomarkers in amyotrophic lateral sclerosis. IJMS 21:1714. https:\/\/doi.org\/10.3390\/ijms21051714","journal-title":"IJMS"},{"key":"3520_CR14","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.3390\/ijms20133148","volume":"20","author":"T Hosaka","year":"2019","unstructured":"Hosaka T, Yamashita T, Tamaoka A, Kwak S (2019) Extracellular RNAs as biomarkers of sporadic amyotrophic lateral sclerosis and other neurodegenerative diseases. IJMS 20:3148. https:\/\/doi.org\/10.3390\/ijms20133148","journal-title":"IJMS"},{"key":"3520_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/cells7110219","volume":"7","author":"C Ricci","year":"2018","unstructured":"Ricci C, Marzocchi C, Battistini S (2018) MicroRNAs as biomarkers in amyotrophic lateral sclerosis. Cells 7:219. https:\/\/doi.org\/10.3390\/cells7110219","journal-title":"Cells"},{"key":"3520_CR16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00018-015-2093-x","volume":"73","author":"I Basak","year":"2016","unstructured":"Basak I, Patil KS, Alves G et al (2016) microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases. Cell Mol Life Sci 73:811\u2013827. https:\/\/doi.org\/10.1007\/s00018-015-2093-x","journal-title":"Cell Mol Life Sci"},{"key":"3520_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/cells9020276","volume":"9","author":"CE Condrat","year":"2020","unstructured":"Condrat CE, Thompson DC, Barbu MG et al (2020) miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis. Cells 9:276. https:\/\/doi.org\/10.3390\/cells9020276","journal-title":"Cells"},{"key":"3520_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/21678421.2020.1746810","volume":"21","author":"H Mitsumoto","year":"2020","unstructured":"Mitsumoto H, Garofalo DC, Santella RM et al (2020) Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 21:263\u2013272. https:\/\/doi.org\/10.1080\/21678421.2020.1746810","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"3520_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13041-015-0161-7","volume":"8","author":"I Takahashi","year":"2015","unstructured":"Takahashi I, Hama Y, Matsushima M et al (2015) Identification of plasma microRNAs as a biomarker of sporadic amyotrophic lateral sclerosis. Mol Brain 8:67. https:\/\/doi.org\/10.1186\/s13041-015-0161-7","journal-title":"Mol Brain"},{"key":"3520_CR20","doi-asserted-by":"publisher","first-page":"134176","DOI":"10.1016\/j.neulet.2019.03.048","volume":"708","author":"M Katsu","year":"2019","unstructured":"Katsu M, Hama Y, Utsumi J et al (2019) MicroRNA expression profiles of neuron-derived extracellular vesicles in plasma from patients with amyotrophic lateral sclerosis. Neurosci Lett 708:134176. https:\/\/doi.org\/10.1016\/j.neulet.2019.03.048","journal-title":"Neurosci Lett"},{"key":"3520_CR21","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/acn3.51674","volume":"9","author":"V Kmetzsch","year":"2022","unstructured":"Kmetzsch V, Latouche M, Saracino D et al (2022) MicroRNA signatures in genetic frontotemporal dementia and amyotrophic lateral sclerosis. Ann Clin Transl Neurol 9:1778\u20131791. https:\/\/doi.org\/10.1002\/acn3.51674","journal-title":"Ann Clin Transl Neurol"},{"key":"3520_CR22","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/jpm12050770","volume":"12","author":"G Gentile","year":"2022","unstructured":"Gentile G, Morello G, La Cognata V et al (2022) Dysregulated miRNAs as biomarkers and therapeutical targets in neurodegenerative diseases. J Pers Med 12:770. https:\/\/doi.org\/10.3390\/jpm12050770","journal-title":"J Pers Med"},{"key":"3520_CR23","doi-asserted-by":"publisher","first-page":"861960","DOI":"10.3389\/fmed.2022.861960","volume":"9","author":"A Panio","year":"2022","unstructured":"Panio A, Cava C, D\u2019Antona S et al (2022) Diagnostic circulating miRNAs in sporadic amyotrophic lateral sclerosis. Front Med 9:861960. https:\/\/doi.org\/10.3389\/fmed.2022.861960","journal-title":"Front Med"},{"key":"3520_CR24","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","volume":"131","author":"JM Shefner","year":"2020","unstructured":"Shefner JM, Al-Chalabi A, Baker MR et al (2020) A proposal for new diagnostic criteria for ALS. Clin Neurophysiol 131:1975\u20131978. https:\/\/doi.org\/10.1016\/j.clinph.2020.04.005","journal-title":"Clin Neurophysiol"},{"key":"3520_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1136\/jmedgenet-2014-102360","volume":"51","author":"C Akimoto","year":"2014","unstructured":"Akimoto C, Volk AE, van Blitterswijk M et al (2014) A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories. J Med Genet 51:419\u2013424. https:\/\/doi.org\/10.1136\/jmedgenet-2014-102360","journal-title":"J Med Genet"},{"key":"3520_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","volume":"169","author":"JM Cedarbaum","year":"1999","unstructured":"Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 169:13\u201321. https:\/\/doi.org\/10.1016\/S0022-510X(99)00210-5","journal-title":"J Neurol Sci"},{"key":"3520_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/01.wnl.0000194316.91908.8a","volume":"66","author":"F Kimura","year":"2006","unstructured":"Kimura F, Fujimura C, Ishida S et al (2006) Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 66:265\u2013267. https:\/\/doi.org\/10.1212\/01.wnl.0000194316.91908.8a","journal-title":"Neurology"},{"key":"3520_CR28","doi-asserted-by":"publisher","first-page":"D152","DOI":"10.1093\/nar\/gkq1027","volume":"39","author":"A Kozomara","year":"2011","unstructured":"Kozomara A, Griffiths-Jones S (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39:D152\u2013D157. https:\/\/doi.org\/10.1093\/nar\/gkq1027","journal-title":"Nucleic Acids Res"},{"key":"3520_CR29","doi-asserted-by":"publisher","first-page":"W460","DOI":"10.1093\/nar\/gkv403","volume":"43","author":"IS Vlachos","year":"2015","unstructured":"Vlachos IS, Zagganas K, Paraskevopoulou MD et al (2015) DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res 43:W460\u2013W466. https:\/\/doi.org\/10.1093\/nar\/gkv403","journal-title":"Nucleic Acids Res"},{"key":"3520_CR30","doi-asserted-by":"publisher","first-page":"D153","DOI":"10.1093\/nar\/gku1215","volume":"43","author":"IS Vlachos","year":"2015","unstructured":"Vlachos IS, Paraskevopoulou MD, Karagkouni D et al (2015) DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions. Nucleic Acids Res 43:D153\u2013D159. https:\/\/doi.org\/10.1093\/nar\/gku1215","journal-title":"Nucleic Acids Res"},{"key":"3520_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27","journal-title":"Nucleic Acids Res"},{"key":"3520_CR32","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gky962","volume":"47","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M, Sato Y, Furumichi M et al (2019) New approach for understanding genome variations in KEGG. Nucleic Acids Res 47:D590\u2013D595. https:\/\/doi.org\/10.1093\/nar\/gky962","journal-title":"Nucleic Acids Res"},{"key":"3520_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-1-4939-3347-1_9","volume":"1395","author":"BC Gomes","year":"2016","unstructured":"Gomes BC, Rueff J, Rodrigues AS (2016) MicroRNAs and cancer drug resistance. Methods Mol Biol 1395:137\u2013162. https:\/\/doi.org\/10.1007\/978-1-4939-3347-1_9","journal-title":"Methods Mol Biol"},{"key":"3520_CR34","doi-asserted-by":"publisher","first-page":"e22833","DOI":"10.1097\/MD.0000000000022833","volume":"99","author":"M Huang","year":"2020","unstructured":"Huang M, Li C, Kong F et al (2020) Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: a meta-analysis. Medicine 99:e22833. https:\/\/doi.org\/10.1097\/MD.0000000000022833","journal-title":"Medicine"},{"key":"3520_CR35","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12957-021-02380-6","volume":"19","author":"M Zheng","year":"2021","unstructured":"Zheng M, Liu J, Meng C et al (2021) Prognostic and clinicopathological importance of microRNA-140 expression in cancer patients: a meta-analysis. World J Surg Onc 19:266. https:\/\/doi.org\/10.1186\/s12957-021-02380-6","journal-title":"World J Surg Onc"},{"key":"3520_CR36","doi-asserted-by":"publisher","first-page":"5834","DOI":"10.3390\/ijms21165834","volume":"21","author":"AM Grimaldi","year":"2020","unstructured":"Grimaldi AM, Nuzzo S, Condorelli G et al (2020) Prognostic and clinicopathological significance of MiR-155 in breast cancer: a systematic review. IJMS 21:5834. https:\/\/doi.org\/10.3390\/ijms21165834","journal-title":"IJMS"},{"key":"3520_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6121696","volume":"2019","author":"J Zhao","year":"2019","unstructured":"Zhao J, Yu H, Yan P et al (2019) Circulating microRNA-499 as a diagnostic biomarker for acute myocardial infarction: a meta-analysis. Dis Markers 2019:1\u201310. https:\/\/doi.org\/10.1155\/2019\/6121696","journal-title":"Dis Markers"},{"key":"3520_CR38","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ijcard.2020.11.004","volume":"327","author":"FL Scolari","year":"2021","unstructured":"Scolari FL, Faganello LS, Garbin HI et al (2021) A systematic review of microRNAs in patients with hypertrophic cardiomyopathy. Int J Cardiol 327:146\u2013154. https:\/\/doi.org\/10.1016\/j.ijcard.2020.11.004","journal-title":"Int J Cardiol"},{"key":"3520_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3109\/1354750X.2014.904001","volume":"19","author":"PB Danborg","year":"2014","unstructured":"Danborg PB, Simonsen AH, Waldemar G, Heegaard NHH (2014) The potential of microRNAs as biofluid markers of neurodegenerative diseases\u2014a systematic review. Biomarkers 19:259\u2013268. https:\/\/doi.org\/10.3109\/1354750X.2014.904001","journal-title":"Biomarkers"},{"key":"3520_CR40","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/ana.25490","volume":"85","author":"J Schulz","year":"2019","unstructured":"Schulz J, Takousis P, Wohlers I et al (2019) Meta-analyses identify differentially expressed microRNAs in Parkinson\u2019s disease. Ann Neurol 85:835\u2013851. https:\/\/doi.org\/10.1002\/ana.25490","journal-title":"Ann Neurol"},{"key":"3520_CR41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13195-021-00862-z","volume":"13","author":"SC Yuen","year":"2021","unstructured":"Yuen SC, Liang X, Zhu H et al (2021) Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer\u2019s disease by meta-analysis and adaptive boosting ensemble learning. Alz Res Therapy 13:126. https:\/\/doi.org\/10.1186\/s13195-021-00862-z","journal-title":"Alz Res Therapy"},{"key":"3520_CR42","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/s41593-021-00936-z","volume":"24","author":"I Magen","year":"2021","unstructured":"Magen I, Yacovzada NS, Yanowski E et al (2021) Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis. Nat Neurosci 24:1534\u20131541. https:\/\/doi.org\/10.1038\/s41593-021-00936-z","journal-title":"Nat Neurosci"},{"key":"3520_CR43","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s12031-018-1204-1","volume":"66","author":"E Dardiotis","year":"2018","unstructured":"Dardiotis E, Aloizou A-M, Siokas V et al (2018) The role of MicroRNAs in patients with amyotrophic lateral sclerosis. J Mol Neurosci 66:617\u2013628. https:\/\/doi.org\/10.1007\/s12031-018-1204-1","journal-title":"J Mol Neurosci"},{"key":"3520_CR44","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fneur.2019.00186","volume":"10","author":"G Joilin","year":"2019","unstructured":"Joilin G, Leigh PN, Newbury SF, Hafezparast M (2019) An overview of MicroRNAs as biomarkers of ALS. Front Neurol 10:186. https:\/\/doi.org\/10.3389\/fneur.2019.00186","journal-title":"Front Neurol"},{"key":"3520_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor JP, Brown RH, Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature 539:197\u2013206. https:\/\/doi.org\/10.1038\/nature20413","journal-title":"Nature"},{"key":"3520_CR46","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1080\/15384101.2022.2060003","volume":"21","author":"T Lai","year":"2022","unstructured":"Lai T, Qiu H, Si L et al (2022) Long noncoding RNA BMPR1B-AS1 facilitates endometrial cancer cell proliferation and metastasis by sponging miR-7-2-3p to modulate the DCLK1\/Akt\/NF-\u03baB pathway. Cell Cycle 21:1599\u20131618. https:\/\/doi.org\/10.1080\/15384101.2022.2060003","journal-title":"Cell Cycle"},{"key":"3520_CR47","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.21873\/anticanres.15904","volume":"42","author":"A Shimazaki","year":"2022","unstructured":"Shimazaki A, Kubo M, Kurata K et al (2022) CCND1 copy number variation in circulating tumor DNA from luminal B breast cancer patients. Anticancer Res 42:4071\u20134077. https:\/\/doi.org\/10.21873\/anticanres.15904","journal-title":"Anticancer Res"},{"key":"3520_CR48","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bbrc.2012.03.006","volume":"420","author":"Y Chen","year":"2012","unstructured":"Chen Y, Guan Y, Liu H et al (2012) Activation of the Wnt\/\u03b2-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice. Biochem Biophys Res Commun 420:397\u2013403. https:\/\/doi.org\/10.1016\/j.bbrc.2012.03.006","journal-title":"Biochem Biophys Res Commun"},{"key":"3520_CR49","doi-asserted-by":"publisher","first-page":"a024117","DOI":"10.1101\/cshperspect.a024117","volume":"7","author":"LI Grad","year":"2017","unstructured":"Grad LI, Rouleau GA, Ravits J, Cashman NR (2017) Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harb Perspect Med 7:a024117. https:\/\/doi.org\/10.1101\/cshperspect.a024117","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3520_CR50","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.neubiorev.2017.01.045","volume":"75","author":"S Shellikeri","year":"2017","unstructured":"Shellikeri S, Karthikeyan V, Martino R et al (2017) The neuropathological signature of bulbar-onset ALS: a systematic review. Neurosci Biobehav Rev 75:378\u2013392. https:\/\/doi.org\/10.1016\/j.neubiorev.2017.01.045","journal-title":"Neurosci Biobehav Rev"},{"key":"3520_CR51","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/sj.cdd.4400741","volume":"7","author":"RS Morrison","year":"2000","unstructured":"Morrison RS, Kinoshita Y (2000) The role of p53 in neuronal cell death. Cell Death Differ 7:868\u2013879. https:\/\/doi.org\/10.1038\/sj.cdd.4400741","journal-title":"Cell Death Differ"},{"key":"3520_CR52","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13195-020-00732-0","volume":"12","author":"G Abate","year":"2020","unstructured":"Abate G, Frisoni GB, Bourdon J-C et al (2020) The pleiotropic role of p53 in functional\/dysfunctional neurons: focus on pathogenesis and diagnosis of Alzheimer\u2019s disease. Alzheimers Res Ther 12:160. https:\/\/doi.org\/10.1186\/s13195-020-00732-0","journal-title":"Alzheimers Res Ther"},{"key":"3520_CR53","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1042\/EBC20200002","volume":"64","author":"Y Sun","year":"2020","unstructured":"Sun Y, Curle AJ, Haider AM, Balmus G (2020) The role of DNA damage response in amyotrophic lateral sclerosis. Essays Biochem 64:847\u2013861. https:\/\/doi.org\/10.1042\/EBC20200002","journal-title":"Essays Biochem"},{"key":"3520_CR54","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cell.2020.12.025","volume":"184","author":"M Maor-Nof","year":"2021","unstructured":"Maor-Nof M, Shipony Z, Lopez-Gonzalez R et al (2021) p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR). Cell 184:689\u2013708.e20. https:\/\/doi.org\/10.1016\/j.cell.2020.12.025","journal-title":"Cell"},{"key":"3520_CR55","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.1007\/s00018-021-03872-0","volume":"78","author":"JR Kok","year":"2021","unstructured":"Kok JR, Palminha NM, Dos Santos SC et al (2021) DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity. Cell Mol Life Sci 78:5707\u20135729. https:\/\/doi.org\/10.1007\/s00018-021-03872-0","journal-title":"Cell Mol Life Sci"},{"key":"3520_CR56","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1874375701004010011","volume":"4","author":"S Ranganathan","year":"2010","unstructured":"Ranganathan S, Bowser R (2010) p53 and cell cycle proteins participate in spinal motor neuron cell death in ALS. Open Pathol J 4:11\u201322. https:\/\/doi.org\/10.2174\/1874375701004010011","journal-title":"Open Pathol J"},{"key":"3520_CR57","doi-asserted-by":"publisher","first-page":"104648","DOI":"10.1016\/j.nbd.2019.104648","volume":"134","author":"Y-Q Yang","year":"2020","unstructured":"Yang Y-Q, Zheng Y-H, Zhang C-T et al (2020) Wild-type p53-induced phosphatase 1 down-regulation promotes apoptosis by activating the DNA damage-response pathway in amyotrophic lateral sclerosis. Neurobiol Dis 134:104648. https:\/\/doi.org\/10.1016\/j.nbd.2019.104648","journal-title":"Neurobiol Dis"},{"key":"3520_CR58","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1073\/pnas.0800546105","volume":"105","author":"YM Ayala","year":"2008","unstructured":"Ayala YM, Misteli T, Baralle FE (2008) TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression. Proc Natl Acad Sci USA 105:3785\u20133789. https:\/\/doi.org\/10.1073\/pnas.0800546105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3520_CR59","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.3390\/nu13072273","volume":"13","author":"E D\u2019Amico","year":"2021","unstructured":"D\u2019Amico E, Grosso G, Nieves JW et al (2021) Metabolic abnormalities, dietary risk factors and nutritional management in amyotrophic lateral sclerosis. Nutrients 13:2273. https:\/\/doi.org\/10.3390\/nu13072273","journal-title":"Nutrients"},{"key":"3520_CR60","doi-asserted-by":"publisher","first-page":"fcaa154","DOI":"10.1093\/braincomms\/fcaa154","volume":"2","author":"FJ Steyn","year":"2020","unstructured":"Steyn FJ, Li R, Kirk SE et al (2020) Altered skeletal muscle glucose\u2013fatty acid flux in amyotrophic lateral sclerosis. Brain Commun 2:fcaa154. https:\/\/doi.org\/10.1093\/braincomms\/fcaa154","journal-title":"Communications"},{"key":"3520_CR61","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nature11280","volume":"488","author":"C-H Wu","year":"2012","unstructured":"Wu C-H, Fallini C, Ticozzi N et al (2012) Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature 488:499\u2013503. https:\/\/doi.org\/10.1038\/nature11280","journal-title":"Nature"},{"key":"3520_CR62","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/1073858417705059","volume":"24","author":"N Hensel","year":"2018","unstructured":"Hensel N, Claus P (2018) The actin cytoskeleton in SMA and ALS: how does it contribute to motoneuron degeneration? Neuroscientist 24:54\u201372. https:\/\/doi.org\/10.1177\/1073858417705059","journal-title":"Neuroscientist"},{"key":"3520_CR63","doi-asserted-by":"publisher","first-page":"1602.e17","DOI":"10.1016\/j.neurobiolaging.2014.10.032","volume":"36","author":"BN Smith","year":"2015","unstructured":"Smith BN, Vance C, Scotter EL et al (2015) Novel mutations support a role for Profilin 1 in the pathogenesis of ALS. Neurobiol Aging 36:1602.e17\u20131602.e27. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.10.032","journal-title":"Neurobiol Aging"},{"key":"3520_CR64","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fneur.2020.00173","volume":"11","author":"JC Koch","year":"2020","unstructured":"Koch JC, Kuttler J, Maass F et al (2020) Compassionate use of the ROCK inhibitor Fasudil in three patients with amyotrophic lateral sclerosis. Front Neurol 11:173. https:\/\/doi.org\/10.3389\/fneur.2020.00173","journal-title":"Front Neurol"},{"key":"3520_CR65","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fnagi.2017.00094","volume":"9","author":"A-E Roser","year":"2017","unstructured":"Roser A-E, T\u00f6nges L, Lingor P (2017) Modulation of microglial activity by Rho-kinase (ROCK) inhibition as therapeutic strategy in Parkinson\u2019s disease and amyotrophic lateral sclerosis. Front Aging Neurosci 9:94. https:\/\/doi.org\/10.3389\/fnagi.2017.00094","journal-title":"Front Aging Neurosci"},{"key":"3520_CR66","doi-asserted-by":"publisher","first-page":"9212","DOI":"10.1128\/MCB.20.24.9212-9224.2000","volume":"20","author":"L Zeng","year":"2000","unstructured":"Zeng L, Sachdev P, Yan L et al (2000) Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation. Mol Cell Biol 20:9212\u20139224. https:\/\/doi.org\/10.1128\/MCB.20.24.9212-9224.2000","journal-title":"Mol Cell Biol"},{"key":"3520_CR67","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fncel.2014.00279","volume":"8","author":"N D\u2019Ambrosi","year":"2014","unstructured":"D\u2019Ambrosi N, Rossi S, Gerbino V, Cozzolino M (2014) Rac1 at the crossroad of actin dynamics and neuroinflammation in amyotrophic lateral sclerosis. Front Cell Neurosci 8:279. https:\/\/doi.org\/10.3389\/fncel.2014.00279","journal-title":"Front Cell Neurosci"},{"key":"3520_CR68","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.mrfmmm.2011.03.004","volume":"717","author":"A Etheridge","year":"2011","unstructured":"Etheridge A, Lee I, Hood L et al (2011) Extracellular microRNA: a new source of biomarkers. Mutat Res 717:85\u201390. https:\/\/doi.org\/10.1016\/j.mrfmmm.2011.03.004","journal-title":"Mutat Res"},{"key":"3520_CR69","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1093\/brain\/awt164","volume":"136","author":"G Bruneteau","year":"2013","unstructured":"Bruneteau G, Simonet T, Bauch\u00e9 S et al (2013) Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression. Brain 136:2359\u20132368. https:\/\/doi.org\/10.1093\/brain\/awt164","journal-title":"Brain"},{"key":"3520_CR70","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jns.2016.06.046","volume":"368","author":"HMT de Andrade","year":"2016","unstructured":"de Andrade HMT, de Albuquerque M, Avansini SH et al (2016) MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis. J Neurol Sci 368:19\u201324. https:\/\/doi.org\/10.1016\/j.jns.2016.06.046","journal-title":"J Neurol Sci"},{"key":"3520_CR71","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jns.2017.07.008","volume":"380","author":"V Pegoraro","year":"2017","unstructured":"Pegoraro V, Merico A, Angelini C (2017) Micro-RNAs in ALS muscle: differences in gender, age at onset and disease duration. J Neurol Sci 380:58\u201363. https:\/\/doi.org\/10.1016\/j.jns.2017.07.008","journal-title":"J Neurol Sci"},{"key":"3520_CR72","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.nbd.2012.08.015","volume":"49","author":"AP Russell","year":"2013","unstructured":"Russell AP, Wada S, Vergani L et al (2013) Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis. Neurobiol Dis 49:107\u2013117. https:\/\/doi.org\/10.1016\/j.nbd.2012.08.015","journal-title":"Neurobiol Dis"},{"key":"3520_CR73","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41420-020-00397-6","volume":"7","author":"G Dobrowolny","year":"2021","unstructured":"Dobrowolny G, Martone J, Lepore E et al (2021) A longitudinal study defined circulating microRNAs as reliable biomarkers for disease prognosis and progression in ALS human patients. Cell Death Dis 7:4. https:\/\/doi.org\/10.1038\/s41420-020-00397-6","journal-title":"Cell Death Dis"},{"key":"3520_CR74","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5414\/NP300889","volume":"35","author":"E Tasca","year":"2016","unstructured":"Tasca E, Pegoraro V, Merico A, Angelini C (2016) Circulating microRNAs as biomarkers of muscle differentiation and atrophy in ALS. Clin Neuropathol 35:22\u201330. https:\/\/doi.org\/10.5414\/NP300889","journal-title":"Clin Neuropathol"},{"key":"3520_CR75","doi-asserted-by":"publisher","first-page":"e89065","DOI":"10.1371\/journal.pone.0089065","volume":"9","author":"JM Toivonen","year":"2014","unstructured":"Toivonen JM, Manzano R, Oliv\u00e1n S et al (2014) MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS One 9:e89065. https:\/\/doi.org\/10.1371\/journal.pone.0089065","journal-title":"PLoS One"},{"key":"3520_CR76","doi-asserted-by":"publisher","first-page":"106883","DOI":"10.1016\/j.clineuro.2021.106883","volume":"208","author":"R Soliman","year":"2021","unstructured":"Soliman R, Mousa NO, Rashed HR et al (2021) Assessment of diagnostic potential of some circulating microRNAs in amyotrophic lateral sclerosis patients, an Egyptian study. Clin Neurol Neurosurg 208:106883. https:\/\/doi.org\/10.1016\/j.clineuro.2021.106883","journal-title":"Clin Neurol Neurosurg"},{"key":"3520_CR77","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1126\/science.1181046","volume":"326","author":"AH Williams","year":"2009","unstructured":"Williams AH, Valdez G, Moresi V et al (2009) MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326:1549\u20131554. https:\/\/doi.org\/10.1126\/science.1181046","journal-title":"Science"},{"key":"3520_CR78","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.3390\/cells10082043","volume":"10","author":"I Casola","year":"2021","unstructured":"Casola I, Scicchitano BM, Lepore E et al (2021) Circulating myomiRs in muscle denervation: from surgical to ALS pathological condition. Cells 10:2043. https:\/\/doi.org\/10.3390\/cells10082043","journal-title":"Cells"},{"key":"3520_CR79","doi-asserted-by":"publisher","first-page":"D977","DOI":"10.1093\/nar\/gkac1010","volume":"51","author":"E Sollis","year":"2023","unstructured":"Sollis E, Mosaku A, Abid A et al (2023) The NHGRI-EBI GWAS catalog: knowledgebase and deposition resource. Nucleic Acids Res 51:D977\u2013D985. https:\/\/doi.org\/10.1093\/nar\/gkac1010","journal-title":"Nucleic Acids Res"},{"key":"3520_CR80","doi-asserted-by":"publisher","first-page":"D1123","DOI":"10.1093\/nar\/gkab957","volume":"50","author":"C Cao","year":"2022","unstructured":"Cao C, Wang J, Kwok D et al (2022) webTWAS: a resource for disease candidate susceptibility genes identified by transcriptome-wide association study. Nucleic Acids Res 50:D1123\u2013D1130. https:\/\/doi.org\/10.1093\/nar\/gkab957","journal-title":"Nucleic Acids Res"},{"key":"3520_CR81","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.chest.2018.06.035","volume":"155","author":"S Niedermeyer","year":"2019","unstructured":"Niedermeyer S, Murn M, Choi PJ (2019) Respiratory failure in amyotrophic lateral sclerosis. Chest 155:401\u2013408. https:\/\/doi.org\/10.1016\/j.chest.2018.06.035","journal-title":"Chest"},{"key":"3520_CR82","doi-asserted-by":"publisher","first-page":"e2592","DOI":"10.1212\/WNL.0000000000009498","volume":"94","author":"HK van der Burgh","year":"2020","unstructured":"van der Burgh HK, Westeneng H-J, Walhout R et al (2020) Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis. Neurology 94:e2592\u2013e2604. https:\/\/doi.org\/10.1212\/WNL.0000000000009498","journal-title":"Neurology"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03520-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03520-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03520-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T10:33:10Z","timestamp":1700476390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03520-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":82,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["3520"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03520-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,2]]},"assertion":[{"value":"28 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Centro Acad\u00e9mico de Medicina de Lisboa (CAML) (ref. no. 94\/19).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All patients signed a written informed consent prior to inclusion into the study. Databases were anonymised and properly treated to safeguard privacy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}